Rhythm Pharmaceuticals Inc (RYTM)
59.77
-0.30
(-0.50%)
USD |
NASDAQ |
Nov 14, 16:00
59.74
-0.03
(-0.05%)
After-Hours: 20:00
Rhythm Pharmaceuticals Gross Profit (Annual): 68.13M for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 68.13M |
| December 31, 2022 | 21.50M |
| December 31, 2021 | 2.555M |
| Date | Value |
|---|---|
| December 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
2019
68.13M
Maximum
2023
18.44M
Average
2.555M
Median
2021
Gross Profit (Annual) Benchmarks
| Eli Lilly and Co | 27.04B |
| TG Therapeutics Inc | 219.53M |
| Regeneron Pharmaceuticals Inc | 11.30B |
| Voyager Therapeutics Inc | -- |
| Mirum Pharmaceuticals Inc | 139.34M |